申请人:Suzuki Yuichi
公开号:US20070219179A1
公开(公告)日:2007-09-20
The present invention relates to a compound represented by the following formula, a pharmacologically acceptable salt thereof, or a use thereof as a pharmaceutical:
wherein R
1
and R
2
are substituents adjacent to each other, and together with two carbon atoms to each of which they attach, form a 5- to 7-membered non-aromatic carbocyclic group or the like, which may be substituted by 1 to 4 substituents selected from (1) an oxo group, (2) a hydroxyl group, and the like; R
3
represents a hydrogen atom or the like; and R
6
represents a hydrogen atom or the like. This compound has a superior strength of binding to a 5-HT1A receptor and an antagonism to the receptor, and is useful as an agent for treating or preventing lower urinary tract symptoms, and particularly symptoms regarding urinary storage.
本发明涉及一种化合物,其表示为以下公式,其药理学上可接受的盐或其用途作为药物:其中R1和R2是相邻的取代基,并与它们附着的两个碳原子一起形成一个5-至7-成员的非芳香族碳环基团或类似物,该基团可以被1至4个取代基所取代,所述取代基包括(1)氧代基、(2)羟基等;R3表示氢原子或类似物;R6表示氢原子或类似物。该化合物具有优越的与5-HT1A受体结合的强度和对受体的拮抗作用,并可用作治疗或预防下尿路症状,特别是涉及尿液储存的症状的药剂。